MAM
Yahoo introduces new finance features
MUMBAI: Yahoo Inc. is revamping the finance section of its web site with more interactive stock charts and other features. The redesigned web page will be unveiled on 17 July.
The new system design has the static, two-dimensional stock chart where scrolling elsewhere on the page was required for getting additional data or a different timeline view removed. Instead, users can stay on the chart itself to view major events such as splits or dividends or drag the timeline to a desired period.
Users can also type in specific dates to create a chart and compare the performance of multiple equities within the same graph. They can then easily print the customized chart or send it to others via e-mail, states a medial release.
Google Inc., had introduced similar interactive chart features when it launched a finance section in March 2006. But Yahoo’s new customisation features raise the bar for its major competitors, reports quote said Charlene Li, an Internet analyst at Forrester Research, as saying. “This takes stock charts to another level. And, you don’t stay the leader if you don’t innovate, ” Li says.
Yahoo will also be adding an online tool for other online publishers to distribute stock charts, quotes and news headlines from Yahoo Finance – all free of charge. The syndication offering, christened the Yahoo Finance Badge, lets web sites of all sizes display market data that Yahoo already receives and processes from the leading stock exchanges.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
